After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

Pheonix-Based Cardiology Group Continues to Expand Access to Care Across ValleyPHOENIX, Dec. 26, 2025 /PRNewswire/ -- ...

I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced electrophysiology and cardiac ...

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Two years after the U.S. FDA approved the first pulsed field ablation system, Abbott Laboratories finally got the regulatory nod for its Volt PFA system. Abbott follows Medtronic plc, Boston ...

Abbott received approval from the Food and Drug Administration for its Volt Pulsed Field Ablation System to treat atrial fibrillation. The medical technology company said Monday that it would soon ...

Trigeminal neuralgia (TN) is a debilitating, chronic syndrome that causes sudden, severe, electric shock-like pain in the face, according to a news release from University Hospitals. While TN isn’t ...